Clinilabs Names Greenberg Director of Expanded Unit
Wednesday, November 26, 2008
New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.
Other personnel news from the clinical trials industry:
Imaging contract research organization WorldCare Clinical (WCC) has appointed John Tomera, Ph.D., to the newly created position of director of regulatory affairs and associate medical director. In this role, Tomera will manage quality assurance and regulatory affairs for the Boston-based company as well as provide medical expertise to WCC project teams. Prior to joining WCC, Tomera served as director of regulatory affairs at Biopure.
Bernard Mulder, M.D., has joined Avantium, as global vice president business development pharma to lead the technology company’s business development team for its pharmaceutical business. Mulder previously held several international positions at Organon.